Corcept Therapeutics Incorporated
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Squarepoint Ops LLC ownership in CORT / Corcept Therapeutics Incorporated

On February 13, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 0 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 6,557 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Squarepoint Ops LLC has a history of taking positions in derivatives of the underlying security (CORT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CORT / Corcept Therapeutics Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -6,557 -100.00 0 -100.00
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 6,557 -74,941 -91.95 545 -90.90 0.0005
2025-08-27 2025-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 81,498 -155,335 -65.59 5,982 -77.89 0.0062
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 81,498 -155,335 5,982 0.0062
2025-08-27 2025-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 236,833 236,833 27,051 0.0328
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 236,833 236,833 27,051 0.0328
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -44,007 -100.00 0 -100.00
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 44,007 -30,504 -40.94 1,109 -54.21 0.0019
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 74,511 16,564 28.58 2,420 53.36 0.0046
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 57,947 -22,813 -28.25 1,579 -12.14 0.0039
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 80,760 80,760 1,797 0.0055
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -22,627 -100.00 0 -100.00
2023-02-14 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 22,627 -10,957 -32.63 460 -46.69 0.0018
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 33,584 -28,261 -45.70 861 -41.47 0.0043
2022-08-15 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 61,845 -50,849 -45.12 1,471 -42.04 0.0082
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 112,694 40,799 56.75 2,538 78.23 0.0109
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 71,895 59,285 470.14 1,424 474.19 0.0038
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 12,610 12,610 248 0.0007
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -63,448 -100.00 0 -100.00
2021-02-16 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 63,448 63,448 1,660 0.0124
2020-11-16 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -18,113 -100.00 0 -100.00
2020-08-14 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 18,113 -46,913 -72.14 305 -60.54 0.0049
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 65,026 65,026 773 0.0198
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -24,697 -100.00 0 -100.00
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 24,697 -148,674 -85.75 349 -81.95 0.0031
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 173,371 29,788 20.75 1,933 14.65 0.0188
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 143,583 32,044 28.73 1,686 13.15 0.0179
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 111,539 111,539 1,490 0.0173
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -57,997 -100.00 0 -100.00
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 57,997 -269,594 -82.30 912 -83.08 0.0121
2018-05-15 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 327,591 297,864 1,002.00 5,389 903.54 0.0856
2018-02-14 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 29,727 4,166 16.30 537 8.92 0.0094
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 25,561 -13,939 -35.29 493 5.79 0.0095
2017-08-14 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 39,500 23,984 154.58 466 174.12 0.0092
2017-05-15 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 15,516 -25,584 -62.25 170 -42.95 0.0047
2017-02-14 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 41,100 41,100 298 0.0122
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-27 2025-06-30 13F/A CORCEPT THERAPEUTICS COM Call 10,900 251.61 800 125.99 n/a n/a n/a
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM Call 10,900 800 n/a n/a n/a
2025-08-27 2025-03-31 13F/A CORCEPT THERAPEUTICS COM Call 3,100 354 n/a n/a n/a
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM Call 3,100 354 n/a n/a n/a
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM Call 28,500 1,319 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-27 2025-06-30 13F/A CORCEPT THERAPEUTICS COM Put 70,000 5,138 n/a n/a n/a
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM Put 70,000 5,138 n/a n/a n/a
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM Put 23,800 1,101 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.